We use cookies, similar technologies and tracking services

This website uses cookies, similar technologies and tracking services (hereinafter referred to as “Cookies”). We need your consent for Cookies, which not only serve to technically display our website, but also to enable the best possible use of our website and to improve it based on your user behavior, or to present content and marketing aligned with your interests. For these purposes, we cooperate with third-party providers (e.g. Salesforce, LinkedIn, Google, Microsoft, Piwik PRO). Through these partners you can also receive advertisements on other websites.
If you consent, you also accept certain subsequent processing of your personal data (e.g. storage of your IP address in profiles) and that our partners may transfer your data to the United States and, if applicable, to further countries. Such transfer involves the risk that authorities may access the data and that your rights may not be enforceable. Please select which Cookies we may use under ”Settings”. More information, particularly about your rights, e.g. to withdraw consent, is available in our Privacy Policy .

Settings

Only technically necessary Cookies

Accept everything

Below, you can activate/deactivate the individual technologies that are used on this website.

Accept All

Essential

These Cookies make a website usable by providing basic functions such as page navigation, language settings, Cookie preferences and access to protected areas of the website. Cookies in this category additionally ensure that the website complies with the applicable legal requirements and security standards. Owing to the essential nature of these Cookies, you cannot prevent their use on our website. Details about these Cookies are available under 'More information'.

Functionality and personalization

These Cookies collect information about your habits when using our web pages and help us to enhance your user experience by tailoring the functions and attractiveness of our web pages based on your previous visits, location and browser settings. They also enable access to integrated third-party tools on our website (e.g., Microsoft Azure for single sign-on authentication). This can involve transferring your data to the United States (for information on the risks involved read Clause 1.5 of our Privacy Policy). If you refuse these Cookies, you might not be able to access the full functionality of the website. Details about the tools we use are available under 'More information'.

Analysis

These Cookies are used to compile basic usage and user statistics based on how our web pages are used (e.g. via Google Tag Manager, Piwik PRO). If you accept these Cookies, you simultaneously consent to your data being processed and transmitted to the United States by services such as Salesforce Pardot (for information on the risks involved read Clause 1.5 of our Privacy Policy). Details about the tools we use are available under 'More information'.

Marketing and social media

These Cookies help third-party sources collect information about how you share content from our website on social media or provide analytical data about your user behavior when you move between social media platforms or between our social media campaigns and our web pages (e.g., LinkedIn Insights). Marketing Cookies from third-party sources also help us measure the effectiveness of our advertising on other websites (e.g. Google Ads, Microsoft Advertising). We use these Cookies to optimize how we deliver our content to you. The third-party sources and social media platforms we use can transfer your data to the United States (for information on the risks involved read Clause 1.5 of our Privacy Policy). If you accept these Cookies, you simultaneously consent to your data being transferred and processed as described above. Details about the tools we use and our social media presence are available under 'More information'.

More information

Save Settings

  • Medtech system from Teamtechnik makes leaktest
Press Release

Dürr Group drives expansion in Medtech automation

Bietigheim-Bissingen, July 1, 2021—Dürr is accelerating the expansion of its automation business in medical technology with another acquisition. Effective July 1, the Group has acquired 100% of the German engineering company Hekuma with sales of around €40 million. The company is one of the leading suppliers of automatic systems for the large-scale production of disposable plastic products used in medication, diagnostics and laboratory technology. Hekuma’s product range perfectly complements the Medtech range of automation specialist Teamtechnik, which is also part of the Dürr Group. Dürr acquired a majority stake in Teamtechnik in February, forming the platform for the targeted growth in the medical technology sector.

“With the acquisition of Hekuma, we are taking the next logical step in building a leading center of competence for automation in medical device production under the umbrella of Teamtechnik,” said Dr. Jochen Weyrauch, who—as Deputy CEO of Dürr AG—is responsible for the Medtech automation business. Inhalers, injectors, blood collection tubes, pipette tips and infusion sets, for example, are manufactured in quantities of several million per year on systems from Hekuma and Teamtechnik. The world market for such disposable medical products is growing by around 8% per year. The main reasons for this are the growth in the world’s population, rising life expectancy and the increasing quality of medical care.

Hekuma GmbH, based in Hallbergmoos near Munich, employs around 180 people. Following successful restructuring in previous years, the company expects a positive operating result in 2021 and successive increases in results in the coming years. Since its foundation in 1974, Hekuma has installed around 5,000 systems worldwide. Systems from Hekuma work in the environment of injection molding machines. They remove freshly manufactured plastic parts, such as trays, vials and sleeves, and add further plastic parts to these in an automated assembly process to form products or preliminary products. This is often followed by further assembly and testing steps, which Teamtechnik serves with its systems. Therefore, Dürr can cover a large part of the automated value creation in medical device production through the combination of Teamtechnik and Hekuma. Furthermore, the customer base is growing, as there is hardly any overlap in the customer bases of Hekuma and Teamtechnik.

In addition to the medical technology sector, which accounts for a good 50% of sales, Hekuma also supplies the automotive industry (25% share of sales). For example, it produces ABS and sensor housings, plug-in connections or parts for transmission electronics on Hekuma systems. Plastic elements for personal care products are also produced with the help of Hekuma technology, such as parts for razors or electric toothbrushes.

Under the umbrella of the Dürr Group, Hekuma will benefit from synergies, for example in purchasing, sales and service. Hekuma’s customer access will improve, particularly in the large markets of China and North America. In addition, Hekuma and Teamtechnik together have a broader and more attractive range of products.

Dürr is acquiring the shares in Hekuma from elexis AG. elexis is a world market leader in the fields of web and strip guiding systems, quality assurance systems and safety components for heavy load logistics and belongs to the plant engineering group SMS group. The parties have agreed to keep the purchase price confidential. The completion of the transaction still has to be approved by the competent antitrust authority.

Dr. Rolf Merte, CEO of elexis AG: “Twenty years ago, the decision to have a diversified product portfolio and to position ourselves in diversified markets was the right decision for our elexis. However, our new strategy is to focus on markets in which we have already achieved stable innovation and market leadership with our high-tech products thanks to our global presence, and to expand our spectrum vertically upwards and also horizontally there. We have not been able to leverage the synergies in our group with HEKUMA that Dürr can now offer them. We are pleased that HEKUMA, with its excellent management team and high technology products, will now be part of a global infrastructure where it will have the opportunity to grow successfully much faster.”

The Dürr Group is one of the world's leading mechanical and plant engineering firms with extensive expertise in automation and digitalization/Industry 4.0. Its products, systems and services enable highly efficient and resource-saving manufacturing processes in different industries. The Dürr Group supplies sectors like the automotive industry, mechanical engineering, chemical, pharmaceutical, medical technology and woodworking industries. It generated sales of € 3.32 billion in 2020. The company has more than 17,000 employees and 121 business locations in 33 countries. Since February 2021, the majority-owned automation specialist Teamtechnik has also been part of the Group. The Dürr Group operates in the market with the brands Dürr, Schenck and HOMAG and with five divisions:

  • Paint and Final Assembly Systems: paint shops as well as final assembly, testing and filling technology for the automotive industry, assembly and test systems for medical devices
  • Application Technology: robot technologies for the automated application of paint, sealants and adhesives
  • Clean Technology Systems: air pollution control, noise abatement systems and coating systems for battery electrodes
  • Measuring and Process Systems: balancing equipment and diagnostic technology
  • Woodworking Machinery and Systems: machinery and equipment for the woodworking industry

This publication has been prepared independently by Dürr AG/Dürr group. It may contain statements which address such key issues as strategy, future financial results, events, competitive positions and product developments. Such forward-looking statements are subject to a number of risks, uncertainties and other factors, including, but not limited to those described in disclosures of Dürr AG, in particular in the chapter “Risks” in the annual report of Dürr AG. Should one or more of these risks, uncertainties and other factors materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performances or achievements of the Dürr group may vary materially from those described in the relevant forward-looking statements. These statements may be identified by words such as “expect,” “want,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “estimate,” “will,” “project” or words of similar meaning. Dürr AG neither intends, nor assumes any obligation, to update or revise its forward-looking statements regularly in light of developments which differ from those anticipated. Stated competitive positions are based on management estimates supported by information provided by specialized external agencies.

Our financial reports, presentations, press releases and ad-hoc releases may include alternative financial metrics. These metrics are not defined in the IFRS (International Financial Reporting Standards). Net assets, financial position and results of operations of the Dürr group should not be assessed solely on the basis of these alternative financial metrics. Under no circumstances do they replace the performance indicators presented in the consolidated financial statements and calculated in accordance with the IFRS. The calculation of alternative financial metrics may vary from company to company despite the use of the same terminology. Further information regarding the alternative financial metrics used at Dürr AG can be found in our → financial glossary on the web page.